ReviewMultiple sclerosis (Houndmills, Basingstoke, England)2019
Beyond rehabilitation: A prevention model of reserve and brain maintenance in multiple sclerosis.
Review in Multiple sclerosis (Houndmills, Basingstoke, England), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
21 citing papers in PubMed, 38 citations in OpenAlex.
- Effects of cognitive rehabilitation and exercise on brain structure in progressive multiple sclerosis: results from the CogEx trial.Journal of neurology · 2025Trial
- Trial
- Rethinking prognosis in multiple sclerosis: a multiaxial perspective.Nature reviews. Neurology · 2026Review
- Importance of physiotherapy and occupational therapy according to people with multiple sclerosis-results from an online survey.Frontiers in rehabilitation sciences · 2026Article
- Advancing multiple sclerosis management in older adults.Nature reviews. Neurology · 2025Article
- Multiple Sclerosis After the Age of 50 Years: A Comparative Analysis of Late Onset and Adult Onset.Journal of clinical neurology (Seoul, Korea) · 2025Article
- BrainAgeNeXt: Advancing brain age modeling for individuals with multiple sclerosis.Imaging neuroscience (Cambridge, Mass.) · 2025Article
- Depicting multiple sclerosis disease course using lesion parenchymal fraction: a quantified expression of the topographical model of multiple sclerosis.Brain communications · 2025Article
- To halt disease progression rehabilitation in MS should start early: No.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024Article
- To halt disease progression rehabilitation in MS should start early: Yes.Multiple sclerosis (Houndmills, Basingstoke, England) · 2024Article
- Towards new perspectives: A scoping review and meta-synthesis to redefine brain health for multiple sclerosis.European journal of neurology · 2024Article
- Brain and cognitive reserve mitigate balance dysfunction in multiple sclerosis.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023Article
- What Is the True Impact of Cognitive Impairment for People Living with Multiple Sclerosis? A Commentary of Symposium Discussions at the 2020 European Charcot Foundation.Neurology and therapy · 2023Article
- Mediterranean diet is linked to less objective disability in multiple sclerosis.Multiple sclerosis (Houndmills, Basingstoke, England) · 2023Article
- MS care: integrating advanced therapies and holistic management.Frontiers in neurology · 2023Review
- Dietary factors and MRI metrics in early Multiple Sclerosis.Multiple sclerosis and related disorders · 2021Article
- Article
- Cognitive Assessment and Rehabilitation for Pediatric-Onset Multiple Sclerosis: A Scoping Review.Children (Basel, Switzerland) · 2020Article
- Mobile Brain/Body Imaging of cognitive-motor impairment in multiple sclerosis: Deriving EEG-based neuro-markers during a dual-task walking study.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2020Article
- Cognitive Impairment and Brain Reorganization in MS: Underlying Mechanisms and the Role of Neurorehabilitation.Frontiers in neurology · 2020Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Persons with multiple sclerosis (MS) experience cognitive and physical decline despite more effective disease-modifying therapies (DMTs), and symptomatic treatments currently have limited efficacy. The best treatment of MS disability may, therefore, be prevention of decline. Here, we present a working model of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.